Mir-34a: a regulatory hub with versatile functions that controls osteosarcoma networks
Author:
Affiliation:
1. Department of Orthopaedics, The Second Xiangya Hospital of Central South University, Hunan, China
2. Hunan Key Laboratory of Tumor Models and Individualized Medicine, The Second Xiangya Hospital of Central South University, Hunan, China
Funder
China Postdoctoral Science Foundation
Publisher
Informa UK Limited
Subject
Cell Biology,Developmental Biology,Molecular Biology
Link
https://www.tandfonline.com/doi/pdf/10.1080/15384101.2022.2087755
Reference101 articles.
1. Osteosarcoma treatment – Where do we stand? A state of the art review
2. Diagnostic and Prognostic Significance of Dysregulated Expression of Circular RNAs in Osteosarcoma
3. miR-34: from bench to bedside
4. Current and future therapeutic approaches for osteosarcoma
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. MicroRNA-34 Family in Cancers: Role, Mechanism, and Therapeutic Potential;Cancers;2023-09-26
2. Hypericin-Mediated Regulation of miR21 and miR34a and Their Target Genes in MCF7 Breast Cancer Cells;Revista Brasileira de Farmacognosia;2023-08-26
3. Hypericin-mediated regulation of miR21 and miR34a and their target genes in MCF7 breast cancer cells;2023-06-05
4. Piperine improves the sensitivity of osteosarcoma cells to doxorubicin by inducing apoptosis and inhibiting the PI3K/AKT/GSK-3β pathway;Journal of Orthopaedic Surgery and Research;2023-03-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3